跳至主要内容
临床试验/IRCT20181030041503N6
IRCT20181030041503N6招募中3 期

the effect of dopamine agonists (cabergoline) on reducing pain in endometriosis patients

Mashhad University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Diagnosis of clinical endometriosis by observing pain and tenderness in the pelvic examination along with endometriosis nodules in the vaginal examination, firm and motionless uterus and confirmed by ultrasound or MRI (observation of endometriosis cysts and nodules)
  • Diagnosis of grade I-IV endometriosis based on r-ASRM criteria during diagnostic laparoscopy during the previous 12 months
  • Dysmenorrhea complaint with EAPP score >30 or >40
  • Normal pap smear

排除标准

  • Endometriosis treated less than 6 months ago with a GNRH agonist or less than 3 months ago danazol or progesterone tablets or less than 1 month ago with oral contraceptives.
  • Breastfeeding
  • Cancers of the uterus, ovaries, cervix and high-grade intraepithelial lesions

研究者

相似试验